Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Bullboard (TSX:LABS)

View:
Prev ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... Next
Comment by okgonowon Jan 08, 2024 3:56pm

RE:RE:RE:could it be

exactly a way to get around the Blackout !!!
56
Discussion
Post by alleyesonmeon Jan 08, 2024 3:04pm

Mr Strachan on X..

S1i...wow.."hurry up FDA" agree this says it all....global pharma partner expecting FDA approval...or clinical trial approval...explosive comments...he probably shouldn't of said ...more  
176
Comment by subaru1ion Jan 08, 2024 2:06pm

RE:RE:RE:could it be

mdj...hit that nail square on the head!!!
56
Discussion
Comment by mdjbrownon Jan 08, 2024 1:23pm

RE:RE:could it be

s1, there is a little restriction called a blackout period preventing insiders from participating in share purchases if material news is imminent, or prior to the release of Quarterly and Annual ...more  
113
Discussion
Comment by subaru1on Jan 08, 2024 12:25pm

RE:could it be

The Ceo and all the insiders can buy all the share they want, like the insiders of any company the all know what we don't know.
63
Discussion
Post by okgonowon Jan 08, 2024 11:24am

could it be

so here is a little tealeafe reading by me..... coukld it be theat Pidduc and the rest of the execs grnted themselves those $.065 options for both last vand this year in advance because they are ...more  
167
Discussion
Post by subaru1ion Jan 08, 2024 10:21am

'all cash merger'...my favorite flavor of "M&A activity"

Pidduck did say, "we have a plan to generate cash" and "M&A opportunities" He should have been a stripper doing a pole dance. 
93
Post by subaru1ion Jan 08, 2024 10:19am

Enjoy!

Johnson & Johnson (NYSE: JNJ) announced today it has entered into a definitive agreement to acquire Ambrx Biopharma, Inc., or Ambrx (NASDAQ: AMAM), a clinical-stage biopharmaceutical company with ...more  
126
Post by subaru1ion Jan 08, 2024 10:15am

J&J>Ambrx>Anebulo=Big pharma>payload mechansim>synthetic

cannabinoids.   Board of directors of Anebulo, Simon Allen who also is CEO of Ambrx.   J&J made their move....just waiting for Pfizer to be announced by LABS. Have a ...more  
126
Post by subaru1ion Jan 08, 2024 10:06am

Who is partnered with LABS now?

(Reuters) -Johnson & Johnson said on Monday it had agreed to buy drug developer Ambrx Biopharma for $2 billion to gain access to its portfolio of targeted cancer therapies.   J&J will ...more  
126
Comment by subaru1ion Jan 08, 2024 8:32am

RE:Questions

My big question is which pharma licensed the rights to the patents for the acid form extractions of cannabinoid molecules because those molecules are much more potent in pharmaceutical applications ...more  
92
Discussion
Comment by Solid1on Jan 08, 2024 6:11am

RE:Questions

There is another possibility, the FDA could also grant exclusive rights again as with GW Pharma 2018, then Labs would have 5 years to earn money and position itself even better on the market 
88
Discussion
Post by Olaf123on Jan 07, 2024 10:29pm

Questions

  I believe they will get cashflow positive in the short-term. Pidduck's guidance have been spot on so far. Things I worry about: If there are no patents applicable on those ...more  
191
Discussion
Comment by subaru1ion Jan 07, 2024 9:11pm

RE:Very interesting that Medipharm has eluded to involvement

After Keith's tweet on X, it's obvious to me at least they got a heads up from their global pharma partner...an update call it....global pharma partner wating on FDA....therefore,  Keith& ...more  
113
Discussion
Prev ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities